Research thatshapes strategy.
Illustrative studies from our Private Equity and Healthcare & Life Sciences practices.

200 owners and managers of boutique fitness studios.
Would studio owners leave the software they run today?

200 nursing and biomedical leaders who choose hospital pumps.
Should the next pump wait for the EHR link?

200 heads of tax who sign their software renewal.
Have the new AI features earned a bigger price rise?

240 patients with Condition Y and adults who care for one.
Where should the new test meet patients first?

180 IT service desk staff and IT leaders who fund the desk.
If AI takes the first line, where does the desk budget go?

1,200 physicians and adult consumers in four countries.
Can one identity carry the company in four markets?

220 current, former and rival-platform contract managers.
Can the platform raise its price and keep its customers?

200 R&D leaders who sign off on lab consumables spend.
Where should new capacity go if AI shrinks lab work?

250 trade buyers and homeowners fitting out kitchens and baths.
Would buyers move fixture spend to a new showroom?

300 adults living with Condition X, treated and untreated.
A monthly dose, or clinic checks moved home?

240 dental lab owners and contract manufacturers.
As labs move from milling to printing, does the work they send out grow?

150 specialists who treat adults with Condition Z.
Which partner drug goes into the pivotal trial?











